BioCentury
ARTICLE | Financial News

DotBio launches with $2.3M seed round

July 30, 2018 12:00 PM UTC

Newco DotBio Pte. Ltd. (Singapore) launched with a $2.3 million seed round led by Futec Biomedical Investments Ltd. of HeungKong Group Ltd. Other undisclosed investors participated in the round.

DotBio spun out of Nanyang Technological University (NTU) with exclusive rights to domain antibody technology and certain assets developed under a deal with Aslan Pharmaceuticals Ltd. (TPEx:6497; NASDAQ:ASLN)...